Henan Taloph Pharmaceutical Stock Co Ltd (600222) — Long-term Investment Intensity

Latest as of September 2019: 5.3%

Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Long-term Investment Intensity of 5.3% as of September 2019. Long-term investments of CN¥137.76 Million represent 5.3% of total assets of CN¥2.62 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 600222 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

5.3%
LT Investments / Total Assets

Long-term Investments

CN¥137.76 Million
CNY

Total Assets

CN¥2.62 Billion
CNY

Country

China
SHG

Henan Taloph Pharmaceutical Stock Co Ltd Long-term Investment Intensity (2015–2018)

This chart shows how Henan Taloph Pharmaceutical Stock Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 5.3%, reflecting long-term investments of CN¥137.76 Million against total assets of CN¥2.62 Billion CNY. For the complete balance sheet picture, see Henan Taloph Pharmaceutical Stock Co Ltd total assets.

Annual Long-term Investment Intensity for Henan Taloph Pharmaceutical Stock Co Ltd (2015–2018)

The table below presents the year-by-year Long-term Investment Intensity for Henan Taloph Pharmaceutical Stock Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Henan Taloph Pharmaceutical Stock Co Ltd for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 4.9% CN¥139.77 Million CN¥2.84 Billion ▲ +0.7 pp
2017 4.3% CN¥120.05 Million CN¥2.81 Billion ▼ -0.3 pp
2016 4.5% CN¥120.18 Million CN¥2.65 Billion ▲ +1.7 pp
2015 2.9% CN¥75.68 Million CN¥2.64 Billion
pp = percentage points